Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results

Fadi Joudi, Bela S. Denes, Carolyn Mies, Alan W Shindel

Research output: Contribution to journalArticle

Abstract

Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The initial pathological diagnosis was organ-confined Gleason 3 + 3 = 6 cancer with metastasis to a pelvic lymph node. Upon review of the pathological specimen and immunohistochemical staining the lymph node tissue concerning for metastatic disease was recharacterized as mesothelial in origin. This case illustrates the importance of second opinions and immunohistochemistry for unexpected or unusual pathological findings.

Original languageEnglish (US)
Pages (from-to)A1
JournalUrology Case Reports
Volume10
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Referral and Consultation
Lymph Nodes
Prostatectomy
Lymph Node Excision
Neoplasms
Immunohistochemistry
Staining and Labeling
Neoplasm Metastasis
Biopsy

Keywords

  • Genomics
  • Lymph nodes
  • Mesothelial inclusions
  • Metastasis
  • Prostate cancer
  • Risk-stratification

ASJC Scopus subject areas

  • Urology

Cite this

@article{7dc78a1e18a4424f99145897df62fc66,
title = "Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results",
abstract = "Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The initial pathological diagnosis was organ-confined Gleason 3 + 3 = 6 cancer with metastasis to a pelvic lymph node. Upon review of the pathological specimen and immunohistochemical staining the lymph node tissue concerning for metastatic disease was recharacterized as mesothelial in origin. This case illustrates the importance of second opinions and immunohistochemistry for unexpected or unusual pathological findings.",
keywords = "Genomics, Lymph nodes, Mesothelial inclusions, Metastasis, Prostate cancer, Risk-stratification",
author = "Fadi Joudi and Denes, {Bela S.} and Carolyn Mies and Shindel, {Alan W}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.eucr.2016.10.016",
language = "English (US)",
volume = "10",
pages = "A1",
journal = "Urology Case Reports",
issn = "2214-4420",
publisher = "Elsevier Saunders",

}

TY - JOUR

T1 - Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results

AU - Joudi, Fadi

AU - Denes, Bela S.

AU - Mies, Carolyn

AU - Shindel, Alan W

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The initial pathological diagnosis was organ-confined Gleason 3 + 3 = 6 cancer with metastasis to a pelvic lymph node. Upon review of the pathological specimen and immunohistochemical staining the lymph node tissue concerning for metastatic disease was recharacterized as mesothelial in origin. This case illustrates the importance of second opinions and immunohistochemistry for unexpected or unusual pathological findings.

AB - Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The initial pathological diagnosis was organ-confined Gleason 3 + 3 = 6 cancer with metastasis to a pelvic lymph node. Upon review of the pathological specimen and immunohistochemical staining the lymph node tissue concerning for metastatic disease was recharacterized as mesothelial in origin. This case illustrates the importance of second opinions and immunohistochemistry for unexpected or unusual pathological findings.

KW - Genomics

KW - Lymph nodes

KW - Mesothelial inclusions

KW - Metastasis

KW - Prostate cancer

KW - Risk-stratification

UR - http://www.scopus.com/inward/record.url?scp=85000910616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000910616&partnerID=8YFLogxK

U2 - 10.1016/j.eucr.2016.10.016

DO - 10.1016/j.eucr.2016.10.016

M3 - Article

AN - SCOPUS:85000910616

VL - 10

SP - A1

JO - Urology Case Reports

JF - Urology Case Reports

SN - 2214-4420

ER -